eCardioVascular Beat

Winter 2011

A welcome alternative to warfarin

At last, a favorable oral anti-thrombin for patients with nonvalvular atrial fibrillation.
[ Douglas Dawley, M.D., cardiologist, Providence Portland Medical Center ]

Why cardiac rehab? The numbers explain

Studies show that patients who receive cardiac rehabilitation fare better than those who don’t.
[ Suzanne Hall, M.D., F.A.C.C., medical director, Providence Cardiac Rehabilitation Program ]

Grand rounds webcast: Treating atrial fibrillation

The evolving management of this common
rhythm disorder.
[ Blair Halperin, M.D., medical director, Providence Center for Advanced Treatment of Atrial Fibrillation ]

Exploring a personalized approach to medication dosing

Clinical trials may discover a role for phenotyping all patients for platelet function.
[ Ty Gluckman, M.D., F.A.C.C., cardiologist, Providence St. Vincent Medical Center ]

Demystifying atherosclerosis and PAD

Some key concepts in identifying, diagnosing and treating the conditions.
[ Aaron Schoenkerman, M.D., F.A.C.C., cardiologist, Providence St. Vincent Medical Center ]

What patients need to know about heart disease*

*but might be afraid to ask. Heart Month is a good reminder to start the conversation.
[ James Beckerman, M.D., F.A.C.C., cardiologist, Providence St. Vincent Medical Center ]

More
Copyright © 2025 Providence Health & Services. All rights reserved.
Clinical Trials | Quality and Outcomes | News and Events | About Us | Contact Us | Make a Referral